Holdings of Birchview Capital, LP

Name: Holdings of Birchview Capital, LP
Creator: Titelia
License: https://titelia.com/en/sources

· Original filing · Compare with another fund · Report an error

Net assets: -
Positions: 61 in 2 countries
Top ten: 61.4 % of the equity sleeve
Filed on: Mar 31, 2026

Portfolio shape

Positions

Rank	Company	Shares	Value
1	KLA Corp	19,883	29.3M $
2	Bristol-Myers Squibb Co	306,268	18.6M $
3	Compass Therapeutics Inc	1,465,867	7.8M $
4	Lam Research Corp	36,000	7.7M $
5	Stoke Therapeutics Inc	210,000	6.8M $
6	Ovintiv Inc	107,500	6.4M $
7	Intellia Therapeutics Inc	445,400	5.7M $
8	Structure Therapeutics Inc	100,000	4.8M $
9	Solid Biosciences Inc	625,980	4.5M $
10	ACADIA Pharmaceuticals Inc	171,000	3.8M $
11	Protagonist Therapeutics Inc	35,000	3.7M $
12	Neurocrine Biosciences Inc	27,190	3.6M $
13	Olema Pharmaceuticals Inc	219,000	3.3M $
14	Relmada Therapeutics Inc	409,387	2.8M $
15	Ocular Therapeutix Inc	320,000	2.7M $
16	United Therapeutics Corp	4,500	2.7M $
17	Nektar Therapeutics	31,000	2.2M $
18	Celldex Therapeutics Inc	70,095	2.2M $
19	EQT Corp	34,619	2.2M $
20	Phathom Pharmaceuticals Inc	195,000	2.2M $
21	Bicycle Therapeutics PLC	463,599	2.2M $
22	Compass Pathways plc	375,000	2.1M $
23	Pacific Biosciences of California Inc	1,500,000	2M $
24	Cytokinetics Inc	30,000	2M $
25	Corcept Therapeutics Inc	47,200	1.9M $
26	Vera Therapeutics Inc	44,000	1.8M $
27	ZENAS BIOPHARMA INC	70,000	1.4M $
28	Foghorn Therapeutics Inc	281,730	1.3M $
29	Ultragenyx Pharmaceutical Inc	62,000	1.3M $
30	KalVista Pharmaceuticals Inc	57,000	1.1M $
31	Immunome Inc	50,000	1.1M $
32	Freeport-McMoRan Inc	18,040	1.1M $
33	Axsome Therapeutics Inc	6,000	1M $
34	Biogen Inc	5,000	916.7K $
35	Lipocine Inc	111,786	893.2K $
36	Travere Therapeutics Inc	29,200	867.5K $
37	Harrow Inc	24,000	846.2K $
38	Verastem Inc	150,000	795K $
39	Apogee Therapeutics Inc	9,000	757.5K $
40	Halozyme Therapeutics Inc	10,100	652.8K $
41	Bridgebio Pharma Inc	8,688	645.2K $
42	Apellis Pharmaceuticals Inc	14,000	563.2K $
43	Ideaya Biosciences Inc	16,860	561.8K $
44	Arcus Biosciences Inc	25,889	559.2K $
45	REGENXBIO Inc	66,270	555.3K $
46	Rocket Pharmaceuticals Inc	127,025	454.8K $
47	Viridian Therapeutics Inc	20,100	393.2K $
48	Pulmonx Corp	250,221	322.8K $
49	Castle Biosciences Inc	12,900	316.7K $
50	Trinity Capital Inc	20,000	294.2K $
51	Candel Therapeutics Inc	60,000	294K $
52	Voyager Therapeutics Inc	74,918	289.2K $
53	Cullinan Therapeutics Inc	20,000	284.2K $
54	Kayne Anderson BDC Inc	20,000	274.4K $
55	Grace Therapeutics Inc	50,000	231.5K $
56	ELUTIA INC	165,094	173.3K $
57	Kyntra Bio Inc	22,566	153K $
58	Phreesia Inc	14,300	119.8K $
59	Zentalis Pharmaceuticals Inc	17,503	41K $
60	DocGo Inc	39,573	24.9K $
61	Gossamer Bio Inc	18,176	6K $

Download this table: CSV, JSON

Sector breakdown

Technology 23.8 %
Health care 14.3 %
Energy 5.5 %
Materials 0.7 %
Unattributed 55.7 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

United States 97.3 %
United Kingdom 2.7 %

Shares are computed on the fund's equities only.

Rank	Country	Lines	Value	Share
1	United States	59	151.2M $	97.28 %
2	United Kingdom	2	4.2M $	2.72 %

Cite this page

Titelia. "Holdings of Birchview Capital, LP". https://titelia.com/en/funds/US13F1618205